| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |